Jeremy Grantham's MEDP Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 34,060 shares of Medpace Holdings, Inc. (MEDP) worth $18.04 M, representing 0.04% of the portfolio. First purchased in 2018-Q1, this medium-term investment has been held for 17 quarters.
Based on 13F filings, Jeremy Grantham has maintained a strategic position in MEDP, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 45,374 shares. Largest reduction occurred in Q3 2024, reducing 38,237 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Medpace Holdings (MEDP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medpace Holdings (MEDP) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +34,060 | New Buy | 34,060 | $529.59 |
| Q4 2025 | -34,097 | Sold Out | 0 | $0.00 |
| Q3 2025 | +319 | Add 0.94% | 34,097 | $514.16 |
| Q2 2025 | +11,768 | Add 53.47% | 33,778 | $313.86 |
| Q1 2025 | +4,818 | Add 28.02% | 22,010 | $304.69 |
| Q4 2024 | +17,192 | New Buy | 17,192 | $332.23 |
| Q3 2024 | -38,237 | Sold Out | 0 | $0.00 |
| Q2 2024 | +3,432 | Add 9.86% | 38,237 | $411.85 |
| Q1 2024 | -16,760 | Reduce 32.50% | 34,805 | $404.15 |
| Q4 2023 | -2,444 | Reduce 4.53% | 51,565 | $306.53 |
| Q3 2023 | +8,635 | Add 19.03% | 54,009 | $242.13 |
| Q2 2023 | +45,374 | New Buy | 45,374 | $240.17 |
| Q1 2019 | -12,500 | Sold Out | 0 | $0.00 |
| Q3 2018 | -6,800 | Reduce 35.23% | 12,500 | $59.92 |
| Q2 2018 | +700 | Add 3.76% | 19,300 | $43.01 |
| Q1 2018 | +18,600 | New Buy | 18,600 | $34.89 |
Jeremy Grantham's Medpace Holdings Investment FAQs
Jeremy Grantham first purchased Medpace Holdings, Inc. (MEDP) in Q1 2018, acquiring 18,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Medpace Holdings, Inc. (MEDP) for 17 quarters since Q1 2018.
Jeremy Grantham's largest addition to Medpace Holdings, Inc. (MEDP) was in Q2 2023, adding 45,374 shares worth $10.9 M.
According to the latest 13F filing for Q2 2026, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 34,060 shares of Medpace Holdings, Inc. (MEDP), valued at approximately $18.04 M.
As of the Q2 2026 filing, Medpace Holdings, Inc. (MEDP) represents approximately 0.04% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Medpace Holdings, Inc. (MEDP) was 54,009 shares, as reported at the end of Q3 2023.